Suppr超能文献

氯胺酮:是抗癫痫药还是促癫痫药?一项系统评价。

Ketamine: Pro or antiepileptic agent? A systematic review.

作者信息

Shehata Islam Mohammad, Kohaf Neveen A, ElSayed Mohamed W, Latifi Kaveh, Aboutaleb Aya Moustafa, Kaye Alan David

机构信息

Ain Shams University, Cairo, Egypt.

Department of Clinical Pharmacy, Alazhar, University, Cairo, 11651, Egypt.

出版信息

Heliyon. 2024 Jan 10;10(2):e24433. doi: 10.1016/j.heliyon.2024.e24433. eCollection 2024 Jan 30.

Abstract

PURPOSE

of Review: This evidence-based systematic review evaluated the safety of ketamine as regard the potential to provoke epilepsy to help better guide anesthesiologists in their practice.

RECENT FINDINGS

Ketamine, originally developed as a dissociative anesthetic, has gained attention for its potential therapeutic applications in various medical conditions, including epilepsy. Ketamine is generally well-tolerated and widely used in anesthesia, however, conflicting data are confusing the anesthesiologists regarding the potential risk of seizures associated with its use. The literature that claimed the proepileeptic property are inconsistent and the mechanism of action is unclear. Moreover, the case reports had been in same certain contexts, such as procedural sedation where ketamine was used as a single agent. On the other hand, the retrospective data analysis confirmed the positive role ketamine plays as antiepileptic agent.

SUMMARY

Many studies have shown promising results for the use of ketamine as antiepileptic agent. In case of epileptic patients, there is no contraindication for using ketamine, however, combining with benzodiazepine or propofol may enhance the safety.

摘要

综述目的

本循证系统评价评估了氯胺酮诱发癫痫的潜在安全性,以帮助麻醉医生在实践中更好地做出指导。

最新发现

氯胺酮最初作为解离麻醉剂开发,因其在包括癫痫在内的各种医疗状况中的潜在治疗应用而受到关注。氯胺酮通常耐受性良好且广泛用于麻醉,然而,相互矛盾的数据让麻醉医生对其使用相关的癫痫发作潜在风险感到困惑。声称氯胺酮具有促癫痫特性的文献并不一致,其作用机制尚不清楚。此外,病例报告多处于特定背景下,如氯胺酮作为单一药物用于程序镇静时。另一方面,回顾性数据分析证实了氯胺酮作为抗癫痫药物的积极作用。

总结

许多研究表明氯胺酮作为抗癫痫药物使用前景良好。对于癫痫患者,使用氯胺酮没有禁忌证,然而,与苯二氮䓬类药物或丙泊酚联合使用可能会提高安全性。

相似文献

1
Ketamine: Pro or antiepileptic agent? A systematic review.
Heliyon. 2024 Jan 10;10(2):e24433. doi: 10.1016/j.heliyon.2024.e24433. eCollection 2024 Jan 30.
2
Combination ketamine and propofol for procedural sedation and analgesia.
Pharmacotherapy. 2007 Nov;27(11):1588-98. doi: 10.1592/phco.27.11.1588.
5
Adverse events associated with ketamine for procedural sedation in adults.
Am J Emerg Med. 2008 Nov;26(9):985-1028. doi: 10.1016/j.ajem.2007.12.005.
9
Combination propofol/ketamine is a safe and efficient anesthetic approach to anorectal surgery.
Dis Colon Rectum. 2006 Jul;49(7):1059-65. doi: 10.1007/s10350-006-0572-8.
10
Role of novel drugs in sedation outside the operating room: dexmedetomidine, ketamine and remifentanil.
Curr Opin Anaesthesiol. 2014 Aug;27(4):442-7. doi: 10.1097/ACO.0000000000000086.

引用本文的文献

1
A Promising Route for Established Indications: A Systematic Review of Nebulized Ketamine in Pain.
Curr Pain Headache Rep. 2025 Apr 30;29(1):81. doi: 10.1007/s11916-025-01394-z.
2
Navigating the depths: A comprehensive narrative review on depression in people with epilepsy.
Heliyon. 2024 Dec 25;11(1):e41389. doi: 10.1016/j.heliyon.2024.e41389. eCollection 2025 Jan 15.
3
Unexpected consequences: A case of ketamine-induced seizure in procedural sedation.
Turk J Emerg Med. 2024 Oct 1;24(4):259-261. doi: 10.4103/tjem.tjem_67_24. eCollection 2024 Oct-Dec.

本文引用的文献

1
Evidence-based guideline on management of status epilepticus in adult intensive care unit in resource-limited settings: a review article.
Ann Med Surg (Lond). 2023 Apr 17;85(6):2714-2720. doi: 10.1097/MS9.0000000000000625. eCollection 2023 Jun.
2
Association Between Induced Burst Suppression and Clinical Outcomes in Patients With Refractory Status Epilepticus: A 9-Year Cohort Study.
Neurology. 2023 May 9;100(19):e1955-e1966. doi: 10.1212/WNL.0000000000207129. Epub 2023 Mar 8.
3
4
Abdominal Compartment Syndrome with Super-K (Ketamine) for Super-R(efractory) Status Epilepticus: A Case Report.
Clin EEG Neurosci. 2024 Mar;55(2):230-234. doi: 10.1177/15500594221134920. Epub 2022 Oct 25.
6
Factors Associated with Refractory Status Epilepticus Termination Following Ketamine Initiation: A Multivariable Analysis Model.
Neurocrit Care. 2023 Apr;38(2):235-241. doi: 10.1007/s12028-022-01578-0. Epub 2022 Aug 24.
7
KETASER01 protocol: What went right and what went wrong.
Epilepsia Open. 2022 Sep;7(3):532-540. doi: 10.1002/epi4.12627. Epub 2022 Jul 25.
8
Ketamine for Management of Neonatal and Pediatric Refractory Status Epilepticus.
Neurology. 2022 Sep 20;99(12):e1227-e1238. doi: 10.1212/WNL.0000000000200889. Epub 2022 Jul 11.
9
The Possible Application of Ketamine in the Treatment of Depression in Alzheimer's Disease.
Neurol Int. 2022 Mar 22;14(2):310-321. doi: 10.3390/neurolint14020025.
10
Early Combination Therapy of Ketamine and Midazolam in Patients with Refractory Status Epilepticus in Hemodynamic Unstable State.
J Epilepsy Res. 2021 Dec 31;11(2):150-153. doi: 10.14581/jer.21023. eCollection 2021 Dec.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验